Search Within

Susan Slovin

Formats
  1. Journal Article (141)
  2. Meeting Abstract (90)
  3. Book Section (7)
  4. Editorial (7)
  5. Review (6)
  6. Conference Paper (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (254)
  2. Genitourinary Oncology Service (254)
  3. Hematologic Malignancies, Division of (254)
  4. Solid Tumor Oncology Division (254)
  5. GSK Faculty (66)
  6. Molecular Pharmacology and Chemistry Program Faculty (54)

More Groups

People
  1. Howard Scher (140)
  2. Michael Morris (90)
  3. Dana Rathkopf (59)
  4. Daniel Danila (39)
  5. William Kelly (31)
  6. Karen Autio (28)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (11)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (81)
  2. Clinical Cancer Research (20)
  3. Cancer (11)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (8)
  5. Seminars in Oncology (8)
  6. Annals of Oncology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. American Association for Cancer Research (31)
  3. Elsevier Inc. (21)
  4. Elsevier Science, Inc. (14)
  5. Springer (12)
  6. Wiley Blackwell (12)

More Publishers

Results (254)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HER-2 profiling and targeting in prostate carcinoma: A phase II trial of trastuzumab alone and with paclitaxel
    Journal Article

    Morris, M. J.; Reuter, V. E.; Kelly, W. K.; Slovin, S. F.; Kenneson, K.; Verbel, D.; Osman, I.; Scher, H. I.
    Cancer (2002)

    Fulltext@MSK | Save
  • BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer
    Meeting Abstract

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Rosen, N.; Scher, H. I.
    European Journal of Cancer (2001)

    Fulltext@MSK | Save
  • Vaccines as treatment strategies for relapsed prostate cancer: Approaches for induction of immunity
    Journal Article

    Slovin, S. F.
    Hematology/Oncology Clinics of North America (2001)

    Fulltext@MSK | Save
  • Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer
    Journal Article

    Kelly, W. K.; Curley, T.; Slovin, S.; Heller, G.; McCaffrey, J.; Bajorin, D.; Ciolino, A.; Regan, K.; Schwartz, M.; Kantoff, P.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • The collection of indirect and nonmedical direct costs (COIN) form: A new tool for collecting the invisible costs of androgen independent prostate carcinoma
    Journal Article

    Sherman, E. J.; Pfister, D. G.; Ruchlin, H. S.; Rubin, D. M.; Radzyner, M. H.; Kelleher, G. H.; Slovin, S. F.; Kelly, W. K.; Scher, H. I.
    Cancer (2001)

    Fulltext@MSK | Save
  • Tn-cluster (c) -KLH/PAM vaccine conjugates in biochemically relapsed prostate cancer (PC): Phase I trial results
    Meeting Abstract

    Slovin, S. F.; Ragupathi, G.; Olkiewicz, K.; Tilak, J.; Terry, K.; Moore, K.; Fazzari, M.; Jakubowiak, J.; Lu, L.; Livingston, P. O.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Prostate cancer: Therapeutic patent review
    Journal Article

    Sepp-Lorenzino, L.; Slovin, S.
    Expert Opinion on Therapeutic Patents (2000)

    Fulltext@MSK | Save
  • Chemotherapy for androgen-independent prostate cancer: Myth or reality
    Journal Article

    Kelly, W. K.; Slovin, S. F.
    Current Oncology Reports (2000)

    Fulltext@MSK | Save
  • Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens
    Journal Article

    Wang, Z. G.; Williams, L. J.; Zhang, X. F.; Zatorski, A.; Kudryashov, V.; Ragupathi, G.; Spassova, M.; Bornmann, W.; Slovin, S. F.; Scher, H. I.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save
  • Specificity analysis of sera from breast and prostate cancer patients vaccinated with MUC1-KLH and MUC2-KLH conjugate vaccines
    Meeting Abstract

    Ragupathi, G.; Adluri, R.; Amaravathi, R.; Howard, L.; Gilewski, T.; Slovin, S. F.; Scher, H. I.; Norton, L.; Livingston, P. O.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save